[ad_1]
health
Reuters Stéphane Mahe
Temporary results show that the cocktail of antibodies “Regeneron” may be effective in preventing “Covid-19”
The company, “Regeneron,” said interim results from the antibody cocktail trial showed the treatment to be effective in preventing “Covid-19” in people already exposed to the virus.
On Tuesday, the company said its treatment could be used as a “negative vaccine” to prevent “Covid-19”, for people at risk of infection, such as those who live in the same home with a person infected with the virus. virus.
The US biotech company said the antibody cocktail, promoted by former US President Donald Trump after a hospital stay with “Covid-19,” resulted in a 100% reduction in symptoms and a reduction in 50% of the overall infection rates.
Read more
The results are based on provisional trial data from about 400 participants, all of whom lived with someone infected with “Covid-19”. The company said the full data set will be released in the next quarter.
“These data, which use REGEN-COV as a negative vaccine, indicate that it may reduce the transmission of the virus as well as the viral load and disease in those who are still infected,” said George Yancopoulos, president and chief scientific officer of Regeneron .
Yancopoulos said the treatment could be used to break the chain of transmission by protecting those closest to the virus.
Regeneron said it will discuss the interim results with health regulators in the United States to explore expanding licenses to use the current antibody mixture in emergency situations.
On Sunday, it was announced that the German government had purchased 200,000 doses of the treatment at a staggering cost of $ 2,400 each.
Source: Reuters
[ad_2]
Source link
